Johns Hopkins researcher Matthew Johnson discusses the future for psychedelics research in light of Oregon's measure to legalize psilocybin for clinical use
Researchers rely on this carefully selected classical and contemporary music playlist to enhance the psychedelic experience for their patients during psilocybin studies
The antidepressant effect of the psilocybin—the active compound in so-called magic mushrooms—was about four times greater than is typically seen in traditional antidepressants currently on the market
Johns Hopkins researchers discover that people who had previously identified as atheists described encountering a "benevolent entity" upon inhaling the psychedelic DMT
/ Johns Hopkins Magazine